RISK OF THROMBOEMBOLISM IN NON-VALVULAR ATRIAL FIBRILLATION AND ADEQUACY OF ANTICOAGULATION IN HIGH RISK PATIENTS

Authors

  • Fawad Farooq
  • Muhammad Hashim
  • Muhammad Rahman Khalid
  • Musa Karim

DOI:

https://doi.org/10.47144/phj.v51i4.1603

Abstract

Objective: To assess frequency of non-valvular AF, with high risk ofthromboembolism and their adequacy of anticoagulation.

Methodology: This study was conducted at National Institute of CardiovascularDisease Karachi from 1st May to 30th September 2017, included patients withnon-valvular AF. Patients were stratified according to thromboembolic risk onCHA DS VASc 2 2 score with more than or equal to 2 as high risk. Information aboutdifferent types of anticoagulant medications was obtained along with recent INRlevel. SPSS 19 was used for the analysis of data and t-test, and Chi-square testswere applied for the assessment and comparison of data. Two sided p≤ 0.05was taken as criteria for statistical significance.

Results: A total of 160 patient were studied,52.5% (84) were males, 85.6% (137)found to have CHA DS -VASc score 2 or above. Out of them 62.8% (86) were 2 2taking warfarin and 13.1% (18) were taking Novel oral anticoagulant(NOAC). Outof those at high risk on warfarin only 20.9% (18), were adequatelyanticoagulated.

Conclusion: In our study majority of patients with non-valvular AF were at higherrisk of thromboembolism with inadequate anticoagulation. Strategies to improveanticoagulation are needed in this group.

Key Words: Atrial fibrillation, Anticoagulation, Thromboembolism,Warfarin, Nonvalvular atrial fibrillation

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Farooq F, Hashim M, Khalid MR, Karim M. RISK OF THROMBOEMBOLISM IN NON-VALVULAR ATRIAL FIBRILLATION AND ADEQUACY OF ANTICOAGULATION IN HIGH RISK PATIENTS. Pak Heart J [Internet]. 2019Feb.27 [cited 2024Nov.23];51(4). Available from: https://pakheartjournal.com/index.php/pk/article/view/1603

Issue

Section

Original Article